Staphylococcal Infections
📧 Sign up to get email alerts when something new happens for Staphylococcal Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Modeling Host-Pathogen Interaction Using Lymphoid Organoids
A National Institute of Allergy and Infectious Diseases study uses lymphoid organoids to model host-pathogen interactions, focusing on Staph…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Unbound Cloxacillin Concentrations During Continuous Infusion [Phase 4]
Phase 4 clinical trial update examining unbound cloxacillin concentrations during continuous infusion for staphylococcal infections.
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Reducing Perioperative S. Aureus Transmission Via OR PathTrac
Georgetown University conducted a clinical trial to reduce perioperative Staphylococcus aureus transmission and surgical site infections usi…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Staphylococcus Haemolyticus in the Neonatal Intensive Care Unit of CHSD in 2023: Analysis and Trends
A completed clinical trial analysis of Staphylococcus haemolyticus infections in newborns in NICUs, focusing on sepsis and catheter-related …
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial [Phase 4]
This entry describes an ongoing Phase 4 randomized controlled trial evaluating adjunctive clindamycin for treatment of skin and soft tissue …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-11-15FDA Approved: MUPIROCIN — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved the original application for mupirocin from Amneal Pharmaceuticals NY LLC (generic mupirocin).
-
CLINICAL_TRIALS trial_result · 2022-06-01Clinical Trial Update: Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection [Phase 2]
Phase 2 trial evaluating exeporfinium chloride gel (XF-73) for reducing Staphylococcus aureus-related infections in surgical patients; study…
-
FDA approval · 2020-07-27FDA Approved: NAFCILLIN — Supplemental Application (Athenex Pharmaceutical Division, LLC.)
FDA approved a supplemental application for Nafcillin (Nafcillin Sodium) by Athenex Pharmaceutical Division, LLC. The action constitutes a s…
-
FDA approval · 2020-07-27FDA Approved: OXACILLIN — Original Application (Fresenius Kabi USA, LLC)
FDA approves Fresenius Kabi USA, LLC's Oxacillin sodium as an original-application (ANDA) generic antibiotic. It is indicated for infections…
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine [Phase 1]
Phase 1 trial assessing adjuvant effect and route of administration on safety and immunogenicity of the NDV-3 vaccine; completed with result…
-
CLINICAL_TRIALS trial_result · 2019-10-28Clinical Trial Update: Ceftriaxone as Home IV for Staph Infections [Phase 4]
Phase 4 clinical trial evaluating home intravenous ceftriaxone for Staphylococcal infections, including osteomyelitis, under investigation.
-
CLINICAL_TRIALS trial_result · 2018-08-16Clinical Trial Update: Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons [NA]
A completed prospective study evaluating MRSA among HIV-infected individuals; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: SA4Ag Safety, Tolerability, and Immunogenicity Study in Japanese Adults [Phase 2]
Pfizer conducted a Phase 2 safety, tolerability, and immunogenicity study of SA4Ag in Japanese adults with Staphylococcal infections; result…
-
FDA approval · 2018-07-10FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Mylan Institutional LLC)
FDA approved an Original Application for vancomycin hydrochloride from Mylan Institutional LLC, confirming its use for treating serious infe…
-
FDA approval · 2018-04-05FDA Approved: NAFCILLIN — Supplemental Application (Baxter Healthcare Corporation)
FDA approved a supplemental application for Nafcillin submitted by Baxter Healthcare Corporation under NDA 050655.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults [Phase 1]
A Phase 1 clinical trial update assessing safety, reactogenicity, and immunogenicity of GlaxoSmithKline's Staphylococcal investigational vac…
-
FDA approval · 2016-03-31FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Eugia US LLC)
The FDA approved a generic vancomycin hydrochloride for injection under an original application from Eugia US LLC. This adds a generic IV op…
-
CLINICAL_TRIALS trial_result · 2015-12-29Clinical Trial Update: Biofilm Formation in Staphylococcus Epidermidis Associated Implant Infections
The completed trial studied biofilm formation by Staphylococcus epidermidis in implant-associated infections. The findings may enhance under…
-
CLINICAL_TRIALS trial_result · 2015-04-22Clinical Trial Update: Reduction of Staph Aureus Carriage by Non-Antibiotic NOZIN® Nasal Sanitizer® Antiseptic [NA]
A completed clinical trial evaluated whether NOZIN Nasal Sanitizer Antiseptic reduces nasal carriage of Staphylococcus aureus, with results …
-
FDA approval · 2015-04-03FDA Approved: NAFCILLIN — Supplemental Application (Baxter Healthcare Corporation)
FDA approved a supplemental application for Nafcillin from Baxter Healthcare Corporation, authorizing changes to the existing NDA. This appr…
-
CLINICAL_TRIALS withdrawal · 2014-05-28Clinical Trial Update: A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis [Phase 1, Phase 2]
The trial evaluating tolerability and early efficacy of the hLF1-11 peptide in bacteremia due to Staphylococcus epidermidis has been withdra…
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Preventing Staphylococcal (Staph) Infection [Phase 4]
Phase 4 trial evaluating ways to prevent Staphylococcal infections has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-02-03Clinical Trial Update: Daptomycin Use for Antimicrobial Prophylaxis in Methicillin Resistant Staphylococcus Aureus (MRSA) Colonized Adult Patients Undergoing Primary Elective Hip, Knee, or Shoulder Arthroplasty [Phase 4]
A Phase 4 trial evaluating daptomycin as antimicrobial prophylaxis in MRSA-colonized adults undergoing primary elective hip, knee, or should…
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants [NA]
A completed trial compared Veronate with placebo for preventing nosocomial Staphylococcal sepsis in premature infants, assessing safety and …
-
CLINICAL_TRIALS trial_result · 2012-07-02Clinical Trial Update: Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan)
Completion of a post-marketing drug use investigation for Zyvox (linezolid) to fulfill regulatory commitments, with results posted in 2012.